ValueAct Capital 13F holdings, Q4 2008
Holdings as of December 31, 2008 · filings on SEC EDGAR · latest filing →
ValueAct Capital disclosed 11 US equity positions worth $2.1bn in its Q4 2008 13F filing. The largest position was SARA LEE CORP at 17.9% of the reported book, followed by IT and VALEANT PHARMACEUTICALS INTL. Against the Q3 2008 filing, it opened 0 new positions, added to 3 and reduced 3 among the top 11 holdings.
What did ValueAct Capital own in Q4 2008? Top 11 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2008 |
|---|---|---|---|---|---|---|---|
| 1 | SARA LEE CORP | 17.9% | $374.1m | 38,214,771 | 0% | held | |
| 2 | IT GARTNER GROUP INC NEW-CL A | Technology | 17.7% | $370.7m | 20,790,013 | 0% | held |
| 3 | VALEANT PHARMACEUTICALS INTL | 14.5% | $303.2m | 13,241,300 | 0% | held | |
| 4 | EFX EQUIFAX INC | Industrials | 13.8% | $287.7m | 10,848,768 | -1% | reduced |
| 5 | THOMSON REUTERS CORP | 11.5% | $239.3m | 10,833,806 | 3% | added | |
| 6 | BFH ALLIANCE DATA SYSTEM CORP | Financial Services | 10.6% | $221.4m | 4,758,220 | 1% | added |
| 7 | MDS INC | 6.8% | $141.7m | 23,107,700 | 0% | held | |
| 8 | DRESSER RAND GROUP INC | 3.8% | $79.5m | 4,606,187 | 15% | added | |
| 9 | ACXIOM CORP | 3.0% | $61.7m | 7,608,026 | -27% | reduced | |
| 10 | SEALY CORPORATION | 0.2% | $5.1m | 2,031,432 | -33% | reduced | |
| 11 | GEVITY HR INC | 0.2% | $5.0m | 3,291,326 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.